| Title | Guidance: Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered To Be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting |
| ToC Doc | Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered To Be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting |
| Docket Number | 2024-13690 |
| Type | Notice |
| Subject | Guidance: Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered To Be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting |
| Publication Date | 2024-06-21 |
| Last Updated Date | 2024-06-20 08:17:26 -0400 |
| Last Public Inspection | 2024-06-20 |
| Filed At | 2024-06-20T08:45:00.000-04:00 |
| 2024-13690_PI.pdf (109140 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 5 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...